Valvular & structural heart disease

Outcomes of transcatheter aortic valve replacement in bicuspid versus tricuspid aortic stenosis with severe calcification

HeartPublished Registry-based cohort study

Main finding · All-cause mortalityResult — go to the resultHazard ratio 0.87

Authors' conclusion

TAVR was observed to be equally safe and effective in bicuspid and tricuspid AS with severe calcification, though bicuspid AS was associated with a higher rate of permanent pacemaker implantation.

Study context

Population
Patients with severe calcification (≥470 mm³) undergoing transcatheter aortic valve replacement (TAVR), Chinese national TAVR registry, April 2014–August 2023870 matched pairs
Participants
870 vs 870
Exposure
TAVR in bicuspid vs tricuspid aortic stenosis (AS)
  • Bicuspid ASn = 870
  • Tricuspid ASn = 870reference
Outcome
All-cause mortality
Follow-up
1 year
Methodological detailspropensity-score matched
  • Propensity-score matched

Main finding

As reported in the abstract

Hazard ratio

0.87

P = 0.62

By group

Observational data: associations, not effects.

Further findings

Technical success

Technical success, bicuspid vs tricuspid AS (no significant difference)
95.1% vs 94.7%
  • Propensity score matched

Procedural complications and in-hospital outcomes

No significant differences in procedural complications or in-hospital outcomes

CV hospitalisation · during follow-up

CV hospitalisation, bicuspid vs tricuspid AS (similar)
1.4% vs 1.7%

Safety

OutcomeP value
New permanent pacemaker implantation8.4% vs 5.6%; higher in bicuspid ASP = 0.03

Stroke · during follow-up

Stroke, bicuspid vs tricuspid AS (similar)
1.5% vs 1.4%

Moderate-to-severe paravalvular leak · during follow-up

Moderate-to-severe paravalvular leak, bicuspid vs tricuspid AS (similar)
3.5% vs 2.5%

Original publication

Outcomes of transcatheter aortic valve replacement in bicuspid versus tricuspid aortic stenosis with severe calcification. Heart. Published 10 May 2025. doi:10.1136/heartjnl-2024-324697

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.